Date & Location
Thursday, October 17, 2024, 8:00 AM - 12:00 PM Pacific Time (Online)
Friday, October 18, 2024, 8:00 AM - 12:00 PM Pacific Time (Online)
Target Audience
Specialties - Advanced Practice Nurse, Fellow/Resident, Medical Student, Nurse, Nurse Assistant, Pharmacist, Pharmacy Technician, Physician, Physician Assistant, Psychologist, Scientist / Researcher, Pharmacologist, Graduate Student, Intern, Trainee
Credits
AMA PRA Category 1 Credits™ (7.25 hours), Non-Physician Attendance (7.25 hours)
Claiming CME Credits
The opportunity to claim credits for the "live event" is now closed.
CMCR plans to offer credits for the CMCR Symposium material as an "enduring event" and will post details on the website when they become available.
Overview
The 2024 CMCR Symposium will showcase the state of the science of the potential therapeutic effects of cannabis and cannabinoids in healthy aging and dementia and in cancer disease process and chemotherapy, overlapping areas in many respects. The format of the CMCR Symposium blends talks by context experts with live discussion and Q&A to explore what is known and not known, evaluate conflicting findings, and provide a roadmap for future research. We will also use this opportunity to contextualize findings from public health reports of growing use of cannabis and cannabinoids among older adults.
Objectives
- Analyze the biological mechanisms of action of cannabinoids and the endocannabinoid system, and relate them to their potential therapeutic roles in conditions affecting healthy aging.
- Analyze the biological mechanisms of action of cannabinoids and the endocannabinoid system, and relate them to their potential therapeutic roles in the treatment of dementia.
- Evaluate the biological mechanisms by which cannabinoids and the endocannabinoid system function, and assess their potential impact on cancer biology.
- Critically assess research methods and apply tools and strategies to conduct rigorous clinical and translational studies on cannabinoids.
- Assess the use of cannabinoids in clinical populations and analyze their impact on public health and safety.
- Review and discuss research priorities in cannabinoid science.
- Facilitate a comprehensive research training experience for trainees, early-stage investigators, and established researchers interested in cannabis research.
- Analyze the biological mechanisms of action of cannabinoids and the endocannabinoid system, and relate them to their potential therapeutic roles in the treatment of dementia.
Registration
Click here to register. Registration is FREE!
Course Directors and Planning Committee
David J. Grelotti, MD - Course Director, Scientific and Program Chair, 2024 CMCR Symposium
Carla Ingle and Felicia Roston - Course Coordinators / Meeting Planners
Faculty Speakers and Moderators
Click here for a list of speakers and moderators at the 2024 CMCR Symposium
Agenda
Click here to see the detailed agenda
Sponsors of the 2024 Symposium
Disclosure Statement
It is the policy of University of California San Diego Continuing Medical Education to ensure that the content of accredited continuing education and related materials is accurate, balanced, objective, and scientifically justified. Education must be free of the influence or control of ineligible companies, and protect learners from promotion, marketing, and commercial bias. All persons in a position to control the content of accredited continuing education must disclose all financial relationships held with ineligible companies, prior to assuming a role in the activity. Those relationships deemed relevant to the education are mitigated prior to the activity through one of the following strategies, depending on the nature of relationship and the role of the person: 1) divesting the financial relationship, 2) altering the individual’s control over content, and/or 3) validating the planning decisions and/or content through independent peer review. All relevant financial relationships are mitigated prior to the activity and mitigation strategies and necessary steps for implementation are communicated to individuals prior to them assuming their role in the activity. Persons who refuse or fail to disclose are disqualified from participating in the activity. Activities are evaluated by participants and peer reviewers to determine if the content was free of bias and met acceptable scientific standards. This information is considered in future activity planning
Accreditation
The University of California San Diego School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of California San Diego School of Medicine designates this Enduring Material activity for a maximum of 7.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 7.25 hours of Category 1 credit for completing this program.
Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 7.25 hours of credit and list "CME Category 1" as the provider number).
Pharmacists: The California Board of Pharmacy accepts as continuing education for pharmacists coursework which meets the standard of relevance to pharmacy practice and is accepted as continuing education by the Medical Board of California.
Psychologists: The California Board of Psychology recognizes and accepts AMA PRA Category 1 Credit(s)™ for license renewal. Psychologists outside of California should check with their state and local boards to ensure that ACCME accredited activities are acceptable for renewal.
Cultural & Linguistic Competency and Implicit Bias
Continuing Medical Education (CME) providers are required by State Assembly Bills 1195 and 241, and the standards created by the California Medical Association (CMA), to include components that address cultural and linguistic competency and implicit bias in CME activities. The planners and presenters of this activity has been asked to provide meaningful consideration of these standards in the selection and presentation of content. Additional information and resources are available on the UC San Diego CME website.
